UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely BioLineRx is implementing good security practices.
BioLineRx, or BioLine, is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
This report shows a preliminary security rating for BioLineRx. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Robust vendor risk management practices has never been more important. It is increasingly one of ...
Regulatory compliance monitoring is a key component of any cybersecurity program. But it's becoming ...
Compare BioLineRx's security performance with other companies